Symmetry Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,466
Closed -$242K 152
2024
Q2
$242K Hold
2,466
0.01% 459
2024
Q1
$276K Hold
2,466
0.02% 443
2023
Q4
$247K Sell
2,466
-2,924
-54% -$290K 0.01% 442
2023
Q3
$468K Sell
5,390
-258
-5% -$23.3K 0.03% 318
2023
Q2
$534K Sell
5,648
-1,215
-18% -$103K 0.03% 317
2023
Q1
$518K Sell
6,863
-2,559
-27% -$193K 0.03% 315
2022
Q4
$724K Buy
9,422
+2,559
+37% +$194K 0.04% 229
2022
Q3
$458K Hold
6,863
0.03% 326
2022
Q2
$359K Hold
6,863
0.02% 408
2022
Q1
$389K Hold
6,863
0.02% 443
2021
Q4
$353K Hold
6,863
0.02% 488
2021
Q3
$338K Hold
6,863
0.02% 526
2021
Q2
$392K Hold
6,863
0.03% 510
2021
Q1
$417K Sell
6,863
-2,123
-24% -$117K 0.03% 464
2020
Q4
$481K Sell
8,986
-2,097
-19% -$109K 0.04% 383
2020
Q3
$520K Buy
11,083
+5,224
+89% +$268K 0.04% 308
2020
Q2
$306K Buy
+5,859
New +$302K 0.04% 228

Other funds holding CAH

Symmetry Partners's CAH Position: Q3 2024 in Review

Symmetry Partners sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 2,466 shares — an estimated $242K sold.

Symmetry Partners first reported a position in CAH in Q2 2020 and held it in 17 quarters. The position peaked at $724K in Q4 2022. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Symmetry Partners reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 2,466 Cardinal Health shares in Q3 2024, an estimated $242K.
  • Symmetry Partners first reported a position in Cardinal Health in Q2 2020 and held it in 17 quarters.
  • Symmetry Partners's Cardinal Health position peaked at $724K in Q4 2022.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.